Wen Zhe Liu

Qianglian Zhichuang (Beijing) Technology Co., Ltd. is a Chinese company that focuses on stroke diagnosis and treatment. The company is based in Beijing, China. The company offers integrated intelligent diagnosis and treatment services for bleeding and ischemic stroke. Qianglian Zhichuang® has developed a one-stop stroke intelligence diagnosis and treatment platform that covers prevention, screening, diagnosis, treatment, rehabilitation, and long-term follow-up. The company collaborates with leading domestic neural clinical centers, including Xuanwu Hospital, Huashan Hospital of Tiantan Hospital, and Changhai Hospital. Qianglian Zhichuang® has applied for dozens of national and provincial research topics and has applied for related fields of hundreds of domestic and international patents. The company was founded in 2016 by Lan Qin, Wen Zhe Liu. Wen Zhe Liu has been the CEO since 2016.